Targeting cuproptosis for cancer therapy: Focus on the anti-tumor immune system by Xuan Zhang, Xiaohong Han

Get full text

Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI by Ning Lou, Ruyun Gao, Yuankai Shi, Xiaohong Han

Get full text

Antitumor effects of a novel chromosome region maintenance 1 (CRM1) inhibitor on non-small cell lung cancer cells in vitro and in mouse tumor xenografts. by Shuai Wang, Xiaohong Han, Jianfei Wang, Jiarui Yao, Yuankai Shi

Get full text

Unraveling the role of HDAC3 as an immunotherapy prognostic biomarker and therapeutic target in advanced non-small cell lung cancer by Liyuan Dai, Liling Huang, Lin Li, Le Tang, Yuankai Shi, Xiaohong Han

Get full text

Global and Chinese trends in oligonucleotide drug clinical development: A comparative analysis by Xiaofei Wu, Shupeng Liu, Dan Liu, Xiuqi Li, Hongyun Wang, Xiaohong Han

Get full text

Multi-Omics Integration Reveals the Impact of Gastrointestinal Microbiota on Feed Efficiency in Tan Sheep by Guohan Sun, Xiaohong Han, Tonggao Liu, Xinrui Zhang, An Shi, Chong Yang, Jinzhong Tao

Get full text

Gambogic acid suppresses osteosarcoma progression through upregulation of FOXO3a by Yawei Hu, Jiawen Wu, Songqing Ye, Hao Zhang, Zengfeng Guo, Xiaohong Han, Jianhua Zhou

Get full text

Spatial transcriptomics reveals prognostically LYZ + fibroblasts and colocalization with FN1 + macrophages in diffuse large B-cell lymphoma by Liyuan Dai, Ning Lou, Liling Huang, Lin Li, Le Tang, Yuankai Shi, Xiaohong Han

Get full text

Multi-omics unveils BCAA metabolism markers L-leucine and HMGCS1 as prognostic marker for immunotherapy efficacy in non-small cell lung cancer by Liyuan Dai, Xinzheng Wang, Ning Lou, Lin Li, Liling Huang, Le Tang, Jiarui Yao, Yuankai Shi, Xiaohong Han

Get full text

Pre-existing Anti-AAV9 antibodies in the Chinese healthy and rare disease populations: Implications for gene therapy by Qian Zhao, Shuangqing Yu, Diyi Fu, Zhen Wu, Jianfang Zhou, Yi Yang, Chen Chen, Ni Wu, Yucan Wang, Wanlin Xi, Ning Lou, Xiaobing Wu, Xiaohong Han

Get full text

Clinical, immune cell, and genetic features predicting survival and long-term response to first-line chemo-immunotherapy treatment for non-small cell lung cancer by Liling Huang, Haohua Zhu, Liyuan Dai, Yu Feng, Xinrui Chen, Zucheng Xie, Xingsheng Hu, Yutao Liu, Xuezhi Hao, Lin Lin, Hongyu Wang, Shengyu Zhou, Jiarui Yao, Le Tang, Xiaohong Han, Yuankai Shi

Get full text

Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for untreated advanced or metastatic pancreatic ductal adenocarci... by Qiang Xu, Xue Zhao, Xianze Wang, Ruizhe Zhu, Yuejuan Cheng, Tao Xia, Heshui Wu, He Tian, Yuping Sun, Mingjun Zhang, Chuntao Gao, Deliang Fu, Xiaojie Wu, Tongsen Zheng, Xiaoyu Yin, Yili Chen, Xiaobing Chen, Zhihua Li, Rufu Chen, Xue Yang, Huan Wang, Quanren Wang, Xiaohong Han, Wenming Wu

Get full text